HCO Named Overall Winner of the 2015-16 Wearables Innovation World Cup

MunichHealth Care Originals won the Health & Wellness category of the Wearables Technologies Innovation World Cup for their Automated Device for Asthma Monitoring and Management (ADAMM) technology. They then went on to beat five other category winners to be named Overall Innovator of 2015/2016. ADAMM was developed at the University of Rochester from a collaboration between Hyekyun Rhee, Ph.D., an associate professor in the School of Nursing, and Mark Bocko, Ph.D., a professor of Electrical and Computer Engineering, as a means to monitor asthma symptoms in order to predict the onset of an asthma event. Health Care Originals has licensed the technology from the University and has been developing different wearable device configurations to get this innovative technology to the public.

 

Experimental Combination Surprises with Anti-HIV Effectiveness

A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected. The potency of the combination treatment, tested so far in mice, suggests that it would be possible to rid the body of HIV for months, reducing the frequency with which patients must take these medications from daily to several times a year.

Read more

Telephus Medical Announces Issuance of Japanese Patent for Anti-MRSA Antibodies

Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan Patent Office has issued Japanese patent number 5,837,215 covering monoclonal antibody compositions that bind and neutralize the endo-β-Nacetylglucosaminidase (Gmd) subunit of staphylococcal bifunctional autolysin and methods to use those antibodies for the treatment and prevention of severe, life-threatening staph infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).

Read more

 

Rochester Researcher Collaborates to Create Temporary Skin Substitute Resistant to Scarring

Richard Phipps, Ph.D., Professor of Environmental Medicine, is collaborating with Aubrey Woodroof, Ph.D. (founder of PermeaDerm, Inc., and inventor of the first bilaminate, biosynthetic, temporary wound dressing, Biobrane®), and BioDot, Inc. (a leader in the field of dispensing low volumes of fluids and powders) to develop a smart, temporary, and anti-scarring wound dressing.

Read the press release from PermeaDerm here.

UR Scientist Wins Novo Nordisk Award to Develop Obesity Drug

University of Rochester Medical Center researcher Richard P. Phipps, Ph.D., won a top scientific award from the pharmaceutical giant Novo Nordisk, to collaborate on a new obesity therapy based on his laboratory’s discoveries.

Phipps, the Wright Family Research Professor of Environmental Medicine, is the first UR faculty to receive the competitive Novo Nordisk Diabetes and Obesity Biologics Science Forum Award. The drug company is providing substantial financial support for the two-year project, which is designed to quickly move basic science in diabetes and obesity to an early stage of drug development known as proof-of-principle.

Read more